v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total revenue $ 2,015,225 $ 1,637,185
Operating expenses    
Cost of services 1,282,247 1,040,945
Cost of goods sold 5,152 3,984
Selling, general and administrative expenses 2,176,099 1,557,322
Depreciation and amortization 142,698 234,462
Total operating expenses 3,606,196 2,836,713
Loss from operations (1,590,971) (1,199,528)
Other income (expense):    
Gain from equity method investment 22,168 15,096
Loss on changes in fair value on warrant liability (3,790,225)
Interest expense (180,323) (307,839)
Total other income (expense) (3,948,380) (292,743)
Net loss from continuing operations (5,539,351) (1,492,271)
Loss from discontinued operations (15,911,315)
Net loss $ (5,539,351) $ (17,403,586)
Net loss from continuing operations per common share:    
Basic $ (3.38) $ (297.87)
Diluted (3.38) (297.87)
Net loss from discontinued operations per common share:    
Basic (3,176.06)
Diluted (3,176.06)
Net loss per common share:    
Basic (3.38) (3,473.93)
Diluted $ (3.38) $ (3,473.93)
Weighted average number of common shares outstanding:    
Basic 1,637,859 5,010
Diluted 1,637,859 5,010
Clinic Revenue [Member]    
Revenue:    
Total revenue $ 1,982,233 $ 1,621,553
Product [Member]    
Revenue:    
Total revenue $ 32,992 $ 15,632